Previous Article | Next Article ![]()
Infection and Immunity, December 2001, p. 7461-7470, Vol. 69, No. 12
Department of Neuroscience, University of
Rome "Tor Vergata,"1 Institute of
Neurobiology and Molecular Medicine, National Council of Research
(CNR),2 Laboratory of Bacteriology and
Medical Mycology, "Istituto Superiore di
Sanità,"4 and
"Istituto Dermopatico dell'Immacolata"
(IDI-IRCCS),6 Rome, Italy; Division of
Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital
and Harvard Medical School, Boston, Massachusetts
021153; and Department of Microbiology
and Immunology, Albert Einstein College of Medicine, Bronx, NY
104615
Received 30 May 2001/Returned for modification 13 July
2001/Accepted 11 September 2001
Nonpeptide antigens (including glycolipids of microbial origin) can
be presented to T cells by CD1 molecules expressed on monocyte-derived
dendritic cells. These HLA unrestricted responses appear to play a role
in host immunity against Mycobacterium tuberculosis and
other pathogenic bacteria. It is known that vaccination with Mycobacterium bovis bacillus Calmette-Guérin (BCG)
has limited efficacy in many clinical settings, although the reasons
for its inadequacy remain unclear. Here we have investigated the
influence of BCG on the induction of CD1b on human monocytes by
granulocyte-macrophage colony-stimulating factor (GM-CSF), which is
believed to be the principal inducer of this antigen-presenting
molecule. Although BCG alone led to a slight induction of CD1b
expression, this agent reduced markedly the ability of GM-CSF to induce
high levels of CD1b that were typically observed in uninfected cells.
Inhibition of CD1b expression in BCG-infected monocytes was apparent at
both the mRNA transcript and CD1b protein levels. Down-regulation of CD1b expression by BCG was mediated, at least in part, by
one or more soluble factors and could not be reversed with high
concentrations of GM-CSF or a variety of other cytokines. The present
results suggest that BCG could diminish the efficiency of
CD1-restricted T-cell responses against nonpeptide mycobacterial
antigens by reducing CD1 expression on antigen-presenting cells. These
findings have potential implications for understanding the nature of
the immune response elicited by BCG in humans and suggest potential strategies that could be important for the development of better vaccines for the prevention of tuberculosis.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7461-7470.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Influence of Mycobacterium bovis
Bacillus Calmette Guérin on In Vitro Induction of CD1 Molecules
in Human Adherent Mononuclear Cells
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Albert Einstein College of Medicine,
Bronx, NY 10461. Phone: (718) 430-3228, -3227, or -3226. Fax: (718)
430-8711. E-mail: porcelli{at}aecom.yu.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»